Insider trade

Officer sold ~$56K of CRL shares in the open market

Traded Aug 6, 2026 · Filed Aug 10, 2026

~$56K
Reported value · 213 sh @ $262.37: 13K
Holds after · shares reported: +8.0%
stock since the trade · S&P 500 -0.6%, $265.51 → $286.83 on Oct 1

Why it stands out

Charles River Laboratories's SVP, Finance and CAO sold $56K of Charles River Laboratories shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 6, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 10, 2026

Officer$25K–$100K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$55,885

Shares × reported transaction price

Timing vs results

1 day after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $265.51 on Aug 6, 2026, at its 52-week high, after a 31% rise over the previous 30 trading days

52-week range $145.57 (Sep 25, 2025) to $265.51 (Aug 6, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $202.10 on Jun 24, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-1.0%	-0.4%	-0.6%
30 days	-3.2%	-1.6%	-1.5%

Past results only. Not a forecast.

Source receipt

Record ID: 0001100682-26-000124
Filed / recorded: Aug 10, 2026, 8:40 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Issuer CIK: 1100682
Ticker: CRL
Reporting person: Michael Gunnar Knell
Relationship: Officer
Officer title: SVP, Finance and CAO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Aug 6, 2026
Transaction code: S
Shares / units: 213
Price per share: $262.37
Acquired / disposed: Disposed (D)
Shares owned after: 12,954
Ownership form: Direct
Amendment: No

Footnotes from the filing

This transaction was executed in multiple trades at prices ranging from $262.26 to $262.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Around the same time

6w ago

21KShares · @ $194.12

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

6w ago

12KShares · @ $208.44

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Director sold ~$10.1M of Charles River Laboratories

Scheduled in advance6w ago